GALWAY, Ireland, Aug. 27,
2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a
global leader in healthcare technology, today announced it will
participate in the 2024 Wells Fargo Healthcare Conference on
Wednesday, September 4, 2024.
Geoff Martha, Medtronic chairman
and chief executive officer, will answer questions on the medtech
industry and on the company beginning at approximately 11:55 a.m. EDT (12:55 p.m.
CDT).
A live webcast of the Q&A session will be available on
September 4, 2024, by clicking on the
Events link at http://investorrelations.medtronic.com.
An archive of the session will be available on the same
webpage later in the day.
About Medtronic
Bold thinking. Bolder actions. We are
Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare
technology company that boldly attacks the most challenging health
problems facing humanity by searching out and finding solutions.
Our Mission — to alleviate pain, restore health, and extend life —
unites a global team of 95,000+ passionate people across more than
150 countries. Our technologies and therapies treat 70 health
conditions and include cardiac devices, surgical robotics, insulin
pumps, surgical tools, patient monitoring systems, and more.
Powered by our diverse knowledge, insatiable curiosity, and desire
to help all those who need it, we deliver innovative technologies
that transform the lives of two people every second, every hour,
every day. Expect more from us as we empower insight-driven care,
experiences that put people first, and better outcomes for our
world. In everything we do, we are engineering the extraordinary.
For more information on Medtronic, visit www.Medtronic.com and
follow on LinkedIn.
Contacts:
|
|
|
|
Erika Winkels
|
Ryan Weispfenning
|
Public
Relations
|
Investor
Relations
|
+1-763-526-8478
|
+1-763-505-4626
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medtronic-chairman-and-ceo-geoff-martha-to-speak-at-the-wells-fargo-healthcare-conference-302232253.html
SOURCE Medtronic plc